Category Archives: Tak Berkategori
COVID-19 vaccine development part 21
Resources on COVID-19 vaccines development: WHO target product profile for COVID-19 vaccine Vaccine landscape Solidarity vaccine trial Access to COVID tools (ACT) Accelerator COVAX facility (WHO) Covax explained (GAVI) COPVAX (CEPI) WHO guidance on ethnics of vaccine allocation
COVID-19 vaccine development part 20
Working together to deliver vaccine to all countries: The Access to Covid-19 Tools (ACT) Accelerator was launched in April 2020 to speed up development and delivery to countries of diagnostics, treatments and vaccines. It includes a health systems connector to … Continue reading
COVID-19 vaccine development part 19
WHO Solidarity vaccine trial (Achieving rapid progress towards global objectives) : Evaluating several different candidate vaccines: Increasing the likelihood of finding several effective vaccines Expenditiously enrolling people at sites with high rates of COVID-19: … Continue reading
COVID-19 vaccine development part 18
WHO COVID-19 Solidarity vaccine trial : On 28 May 2020, WHO announced the launch of a coordinated international, concurrent randomized controlled Phase III trial of different vaccine candidates A trial in several sites at once will help speed evaluation and … Continue reading
COVID-19 vaccine development part 17
COVID-19 vaccine candidates in Phase III trials : As of 02 October 2020 there are 42 COVID-19 candidate vaccines in clinical evaluation of which 10 in phase III trials There are another 151 candidate vaccines in preclinical evaluation Phase III … Continue reading